Vesalius Biocapital

Vesalius Biocapital is a European venture capital firm dedicated to investing in companies active in human health. The firm deploys capital through specialized funds, focusing on therapeutics, medical devices, and diagnostics across various development stages. Its investment strategy targets opportunities with proprietary technology, robust intellectual property, and strong data-backed competitive advantages, frequently taking on a lead investor role.

The firm was co-founded in 2007 by Stéphane Verdood, who brought extensive experience in the life sciences industry, business consulting, and mergers and acquisitions to the venture. This foundational insight centered on identifying and nurturing promising companies within the European health sector that required strategic capital and guidance to mature their innovative solutions.

Vesalius Biocapital serves early-stage and developing companies seeking capital and partnership to advance their innovations in medicine. The firm's long-term vision is to contribute significantly to the progress of human health by supporting the growth and development of companies that offer novel treatments and diagnostic tools.